CullmanTimes.com - Cullman, Alabama

Health

October 8, 2012

Alzheimer drug shows some promise in mild disease

BOSTON — Combined results from two studies of an experimental Alzheimer’s drug suggest it might modestly slow mental decline, especially in patients with mild disease.

Taken separately, the studies missed their main goals to significantly slow the mind-robbing disease. But pooled results found 34 percent less decline in mild Alzheimer’s patients compared to those on a dummy treatment for 18 months.

Doctors say the results do not seem strong enough to win approval of the drug now. But they show researchers are on the right track by trying to clear the sticky deposits that clog patients’ brains.

The drug is being developed by Eli Lilly & Co. and is called solanezumab (sol-ah-NAYZ-uh-mab). Results were reported Monday at an American Neurological Association conference in Boston.

About 35 million people worldwide have dementia, and Alzheimer’s is the most common type. In the U.S., about 5 million have Alzheimer’s. Current medicines such as Aricept and Namenda just temporarily ease symptoms. There is no known cure.

Solanezumab is one of three drugs in late-stage testing that seek to alter the course of Alzheimer’s.  The two studies each had about 1,000 patients, about two-thirds with mild disease and one-third with moderately severe Alzheimer’s, in 16 countries. Their average age was 75.

The main measures were two tests, one reflecting language, memory and thinking and the other, ability to perform daily activities such as eating and grooming. The combined results on the mild disease patients showed a nearly 2-point difference in the roughly 90-point score on thinking abilities.

“It’s a small difference,” said Dr. Rachelle Doody of Baylor College of Medicine. She heads a nationwide research network funded by the National Institute on Aging that did an independent analysis of Lilly’s results on the studies and presented them Monday at the conference.

Still, “you slow the decline” with the drug, she said.

Independent experts agreed.

“It’s certainly not the home run we all wanted, but we’re very encouraged by these results,” said Maria Carillo, senior director of medical and scientific relations for the Alzheimer’s Association, which had no role in the research.

A Lilly official said the company will discuss next steps with the Food and Drug Administration.

The price of Lilly shares rose more than 2 percent, or $1.22, to $49.45 in heavy Monday afternoon trading while the Standard & Poor’s 500 index fell slightly. The shares set a new 52-week high price of $49.78 before retreating slightly.

———

Online:

Alzheimer’s info: http://www.alzheimers.gov  

Alzheimer’s Association: http://www.alz.org 

 

1
Text Only
Health
  • COMMENTARY: An alternative diagnosis to ADHD: Schoolchildren need more time to move

    The Centers for Disease Control and Prevention tells us that in recent years, there has been a jump in the percentage of young people diagnosed with attention deficit and hyperactivity disorder, commonly known as ADHD: 7.8 percent in 2003 to 9.5 percent in 2007 to 11 percent in 2011.

    July 18, 2014

  • Guideline: Most healthy women can skip pelvic exam

    No more dreaded pelvic exam? New guidelines say most healthy women can skip the yearly ritual.

    July 1, 2014

  • Sanofi targets fake Viagra market with non-prescription Cialis

    Sanofi sees an attractive opportunity in the rampant market for counterfeit Viagra: luring men away from dodgy online pharmacies with an over-the-counter version of a competing erection drug.

    June 5, 2014

  • Hospital charges to treat chest pain jump 10 percent in a year

    The charge to treat Medicare patients with chest pain at U.S. hospitals rose 10 percent to $18,568 in just a year, the biggest rise seen among the most common inpatient procedures, according to federal data.

    June 2, 2014

  • Study: Both men and women feel less stress at work than at home

    In a newly released study in the Journal of Science and Medicine, researchers carefully examined the levels of the stress hormone, cortisol, of a variety of workers throughout the day. The data clearly showed that both men and women are significantly less stressed out at work than they are at home.
     And the women they studied said they were happier at work. While the men said they felt happier at home.

    May 26, 2014

  • Jobless contend with weight gain as they search for work

    A subject long ignored by policymakers, and one that unemployment counselors are too sheepish to raise with job seekers, the link between bulging waistlines and joblessness is now of intense interest to researchers studying the long-term effects of the country's economic malaise.

    May 12, 2014

  • COMMENTARY: Helmets won't protect your kids from concussions

    When I was a kid, helmets were for motorcyclists. Now I see children wearing helmets when they're scooting down sidewalks, skating, skiing, sledding and playing soccer. Last week one of my friends saw a helmeted kid power-walking in Prospect Park. You can even buy $40 baby helmets on Amazon, because, according to the product description, "babies will always fall taking their first steps."

    May 2, 2014

  • 400px-Cannabis_Plant.jpg How bad is marijuana for your health?

    The Journal of Neuroscience recently published a study linking recreational marijuana use to subtle changes in brain structure. The researchers, led by Jodi Gilman of Massachusetts General Hospital, identified increased gray matter density in the left nucleus accumbens and some bordering areas.

    May 1, 2014 1 Photo

  • American sunscreens need an upgrade

    The last time a new sunscreen ingredient came on the U.S. market, the Y2K bug was threatening to destroy our way of life. Intel had just introduced the Pentium III processor, featuring an amazing 500 MHz of computing power.

    April 24, 2014

  • Cuba is running out of condoms

    The newest item on Cuba's list of dwindling commodities is condoms, which are now reportedly in short supply. In response, the Cuban government has approved the sale of expired condoms.

    April 23, 2014